Can a healthy adult who has received one dose of Twinrix and a subsequent dose of Engerix‑B (hepatitis B vaccine) receive a monovalent hepatitis A vaccine (e.g., Havrix or Vaqta) one week later?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Hepatitis A Vaccine Be Given One Week After Engerix-B?

Yes, you can administer a monovalent hepatitis A vaccine (Havrix or Vaqta) one week after Engerix-B without any safety concerns or reduction in immunogenicity. Inactivated vaccines such as hepatitis A and hepatitis B can be given simultaneously or at any interval without interference. 1

Rationale for Concurrent or Sequential Administration

  • Inactivated vaccines do not require minimum intervals between different vaccine types. The CDC explicitly states that inactivated vaccines may be administered at the same visit or separated by any interval without compromising immune response. 1

  • Mixing monovalent hepatitis A and B vaccines is safe and effective. Clinical trials demonstrate that switching between monovalent vaccines (Havrix, Vaqta, Engerix-B) and combined vaccines (Twinrix) at any point in the series does not reduce seroprotection rates and may even improve immunogenicity. 2

  • No waiting period is required after Engerix-B before starting hepatitis A vaccination. Because both are inactivated vaccines, there is no biological reason to delay hepatitis A vaccination after receiving hepatitis B vaccine. 1

Practical Scheduling Considerations

  • If the patient has already received one dose of Twinrix followed by Engerix-B, you can now administer monovalent hepatitis A vaccine to complete hepatitis A protection. The patient has received:

    • Hepatitis A: 1 dose (from Twinrix)
    • Hepatitis B: 2 doses (from Twinrix + Engerix-B)
  • Complete the hepatitis A series by giving a second dose of monovalent hepatitis A vaccine 6–12 months after the first Twinrix dose (for Havrix) or 6–18 months (for Vaqta). 1

  • Complete the hepatitis B series by giving a third dose at least 8 weeks after the Engerix-B dose and at least 16 weeks after the first Twinrix dose. The standard timing places this third hepatitis B dose at month 6 from the initial Twinrix dose. 1, 3

Corrected Vaccination Schedule

Timing Vaccine Hepatitis A Doses Hepatitis B Doses
Month 0 Twinrix 1 1
Month 1 Engerix-B 1 2
Week after Engerix-B Havrix or Vaqta 2 2
Month 6 Twinrix or Engerix-B 2 3

1, 3

Alternative Approach: Use Twinrix for Remaining Doses

  • If both hepatitis A and B protection are indicated, simply continue with Twinrix for the third dose at month 6. This completes both series simultaneously and avoids the need for separate monovalent vaccines. 1

  • The Engerix-B dose given at month 1 counts as a valid second hepatitis B dose because mixing hepatitis B vaccine manufacturers does not compromise immunogenicity. 1, 3

Common Pitfalls to Avoid

  • Do not delay hepatitis A vaccination unnecessarily. There is no minimum interval required between inactivated vaccines, so waiting serves no purpose and only prolongs the period of incomplete protection. 1

  • Do not restart either vaccine series. The CDC emphasizes that interrupted or mixed-brand series should never be restarted; simply continue from where you left off. 1, 3, 4

  • Do not confuse the 4-day grace period (which applies to minimum intervals within a single vaccine series) with the absence of any required interval between different inactivated vaccines. The grace period is irrelevant here because no minimum interval exists between hepatitis A and hepatitis B vaccines. 1

  • Do not use Twinrix solely for hepatitis B completion when hepatitis A is not indicated. If the patient does not need hepatitis A protection, complete the hepatitis B series with Engerix-B alone to avoid unnecessary antigen exposure. 1, 3

References

Guideline

Adult Hepatitis A and B Vaccination Schedules

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hepatitis B Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hepatitis B Vaccine Dosing and Schedule Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended timing for the third dose of Twinrix (hepatitis A and B vaccine) in a healthy adult if the 21-day mark is missed in the rapid 0,7,21 schedule?
What are the brand names of Hepatitis A vaccines?
What are the indications, dosing schedule, contraindications, pregnancy considerations, side effects, and alternative options for Engerix‑B (recombinant hepatitis B surface antigen vaccine)?
What is the recommended Engerix-B (hepatitis B vaccine) vaccination schedule for different patient populations?
I gave Engerix B (hepatitis B vaccine) by mistake as the second dose of Twinrix (combined hepatitis A and B vaccine); how should I complete the hepatitis A and B vaccination series?
What Food and Drug Administration (FDA)-approved medications and typical starting doses are recommended for treating bipolar disorder in adolescents (10‑17 years)?
How is pulmonary artery pressure measured using a Swan‑Ganz (pulmonary artery) catheter and what are the normal pressure values?
Is it safe to split a 15 mg meloxicam tablet in half?
How can I differentiate schizophrenia from bipolar mania in a patient presenting with psychotic symptoms?
For a patient with refractory gastroesophageal reflux disease on omeprazole 40 mg twice daily who is also taking budesonide/formoterol (Symbicort), tiotropium, montelukast, and olopatadine/mometasone (Ryaltris), which proton‑pump inhibitor—omeprazole or esomeprazole—is preferable?
I have purpura on my feet after surgery; what could be causing it and how should I evaluate and manage it?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.